KKR and OMX Ventures lead $55 million seed funding round Replay’s genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform Company is led and supported by a world-class team […]
WAYNE, Pa. — Argosy Healthcare Partners (“AHP”), a lower middle market private equity investor focused exclusively on healthcare, and a division of Argosy Capital, a diversified investment firm with $2.7 billion in assets under management, is pleased to announce that it completed the recapitalization and merger of Hudson Robotics (“HR”) and Art Robbins Instruments (“ARI” and, together with HR, […]
Navinci Diagnostics AB, a Swedish life science company developing innovative tools for spatial proteomics research, announces the closing of a SEK 90 million financing round. The round was led by Segulah Medical Acceleration (”SMA”), a Scandinavia-based life science-focused investment company, together with existing shareholders, including Landegren Gene Technology AB, Nexttobe AB, and Beijer Ventures AB. […]
Halo Labs forms partnership with Agilent Technologies in Series C funding BURLINGAME, CA – Halo Labs, a leading life science instrumentation company announced it has raised $6M in series C financing. The round was led by Agilent Technologies Inc. and includes participation from existing investors Research Corporation Technologies, Broad Oak Capital Partners, BioAdvance, and members […]
Companies will participate in a customized mentorship program and compete for $250K in Prizes on Oct. 13 in Carlsbad, Calif. LOS ANGELES — BioTools Innovator, the first accelerator focused on life science tools and diagnostics to advance cutting-edge research and improve human health, announced that 14 companies have been selected to participate in its annual […]
Edinburgh, UK – Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6m funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS). The fundraising round by Cytomos was led by existing investor Archangels with participation from Scottish Enterprise and Old College Capital. Cytomos […]
Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technology CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm. Typically investing in high potential, innovative […]
BEIJING — On June 15, 2022, MegaRobo Technologies Ltd. announced that it has closed a ~US$300mm Series C financing, led by Goldman Sachs Asset Management, Asia Investment Capital, and GGV Capital, and co-invested by Sinovation Ventures (existing shareholder), Pavilion Capital, Starr Capital, U-Member Capital, RedView Capital, Harvest Capital and Taihe Capital. The proceeds will help MegaRobo continue its […]
Armed with the world’s largest virus-bacteria interactome repository, Phase Genomics to engineer a predictive engine for the development of new therapies against drug-resistant biothreats SEATTLE —Phase Genomics, Inc., a leading developer of proximity ligation-based genomic solutions, today announced $5.5MM in combined non-dilutive funding from the Bill and Melinda Gates Foundation and the National Institute of […]
Proceeds to accelerate standardization of single-cell spatial genomics research through broader adoption of Vizgen’s MERSCOPE™ Platform CAMBRIDGE, Mass. — Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced the closing of $85.2 million Series C financing. The financing was led by Blue Water Life Science Advisors […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
